Log in to save to my catalogue

A human antibody against pathologic IAPP aggregates protects beta cells in type 2 diabetes models

A human antibody against pathologic IAPP aggregates protects beta cells in type 2 diabetes models

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_68eb80d31bdf42208e648a12724a93bf

A human antibody against pathologic IAPP aggregates protects beta cells in type 2 diabetes models

About this item

Full title

A human antibody against pathologic IAPP aggregates protects beta cells in type 2 diabetes models

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2023-10, Vol.14 (1), p.6294-6294, Article 6294

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

In patients with type 2 diabetes, pancreatic beta cells progressively degenerate and gradually lose their ability to produce insulin and regulate blood glucose. Beta cell dysfunction and loss is associated with an accumulation of aggregated forms of islet amyloid polypeptide (IAPP) consisting of soluble prefibrillar IAPP oligomers as well as insolu...

Alternative Titles

Full title

A human antibody against pathologic IAPP aggregates protects beta cells in type 2 diabetes models

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_68eb80d31bdf42208e648a12724a93bf

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_68eb80d31bdf42208e648a12724a93bf

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-023-41986-0

How to access this item